Last updated: 15 June 2019 at 8:10am EST

Partners L P/Ilbiotechnolog... Net Worth




The estimated Net Worth of Partners L P/Ilbiotechnolog... is at least $237 Million dollars as of 26 November 2013. Partners Ilbiotechnolog owns over 527,505 units of Ligand Pharmaceuticals stock worth over $207,090,697 and over the last 12 years Partners sold LGND stock worth over $30,210,211.

Partners Ilbiotechnolog LGND stock SEC Form 4 insiders trading

Partners has made over 2 trades of the Ligand Pharmaceuticals stock since 2013, according to the Form 4 filled with the SEC. Most recently Partners sold 527,505 units of LGND stock worth $30,210,211 on 26 November 2013.

The largest trade Partners's ever made was selling 527,505 units of Ligand Pharmaceuticals stock on 26 November 2013 worth over $30,210,211. On average, Partners trades about 283,553 units every 154 days since 2013. As of 26 November 2013 Partners still owns at least 2,008,834 units of Ligand Pharmaceuticals stock.

You can see the complete history of Partners Ilbiotechnolog stock trades at the bottom of the page.



Insiders trading at Ligand Pharmaceuticals

Over the last 21 years, insiders at Ligand Pharmaceuticals have traded over $205,340,014 worth of Ligand Pharmaceuticals stock and bought 2,116,600 units worth $27,601,439 . The most active insiders traders include Partners L P/Ilbiotechnolog..., Partners L P/Ilbiotechnolog..., and Partners L P/Ilbiotechnolog.... On average, Ligand Pharmaceuticals executives and independent directors trade stock every 22 days with the average trade being worth of $2,239,733. The most recent stock trade was executed by Octavio Espinoza on 28 August 2024, trading 753 units of LGND stock currently worth $50,090.



What does Ligand Pharmaceuticals do?

ligand, a pharmaceutical company, is assembling a large and diverse portfolio of current and near-term commercial revenue generating assets to assist the long-term financial growth of the company. we operate this business on a lean cost structure that allows us to maximize cash flow and ultimately deliver a meaningful return for our shareholders.



What does Ligand Pharmaceuticals's logo look like?

Ligand Pharmaceuticals, Inc. logo

Complete history of Partners Ilbiotechnolog stock trades at Ligand Pharmaceuticals

Date
#
Company
Insider
Trans.
Transaction
Shares Price per share Total value Shares after Source
26 Nov 2013 Partners L P/Ilbiotechnolog...
Sale 527,505 $57.27 $30,210,211
26 Nov 2013
2,008,834
23 Jan 2013 Partners L P/Ilbiotechnolog...
Buy 39,600 $19.78 $783,288
23 Jan 2013
2,163,412


Ligand Pharmaceuticals executives and stock owners

Ligand Pharmaceuticals executives and other stock owners filed with the SEC include: